|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
1 | AN ACT concerning health.
| ||||||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||
3 | represented in the General Assembly:
| ||||||||||||||||||||||||
4 | Section 1. Short title. This Act may be cited as the MRSA | ||||||||||||||||||||||||
5 | Screening, Prevention, and Reporting Act for State Residential | ||||||||||||||||||||||||
6 | Facilities. | ||||||||||||||||||||||||
7 | Section 5. Definition. In this Act, "State residential | ||||||||||||||||||||||||
8 | facility" or "facility" means: any Department of Human Services | ||||||||||||||||||||||||
9 | operated residential facility, including any State mental | ||||||||||||||||||||||||
10 | health hospital, State developmental center, or State | ||||||||||||||||||||||||
11 | residential school for the deaf and visually impaired; any | ||||||||||||||||||||||||
12 | Department of Corrections operated correctional center, work | ||||||||||||||||||||||||
13 | camp or boot camp, or adult transition center; and any | ||||||||||||||||||||||||
14 | Department of Juvenile Justice operated juvenile center or boot | ||||||||||||||||||||||||
15 | camp.
| ||||||||||||||||||||||||
16 | Section 10. MRSA control procedures. In order to improve | ||||||||||||||||||||||||
17 | the prevention of infections due to methicillin-resistant | ||||||||||||||||||||||||
18 | Staphylococcus aureus ("MRSA"), every State residential | ||||||||||||||||||||||||
19 | facility shall establish MRSA control procedures that include | ||||||||||||||||||||||||
20 | the following features: | ||||||||||||||||||||||||
21 | (1) Screening and surveillance. Upon admission or | ||||||||||||||||||||||||
22 | incarceration, all individuals shall be screened for MRSA |
| |||||||
| |||||||
1 | infection and colonization. | ||||||
2 | (2) Reporting. | ||||||
3 | (A) All confirmed MRSA and other | ||||||
4 | antibiotic-resistant infections shall be documented in | ||||||
5 | the resident, patient, student, or inmate's medical | ||||||
6 | record. | ||||||
7 | (B) All confirmed MRSA and other | ||||||
8 | antibiotic-resistant infections shall be reported to | ||||||
9 | the director of the department operating the facility | ||||||
10 | and to the Department of Public Health. The report | ||||||
11 | shall indicate whether the MRSA infection was present | ||||||
12 | on intake or contracted at the facility, if known. | ||||||
13 | (3) Prevention. | ||||||
14 | (A) Education. Employees, residents, patients, | ||||||
15 | students, and inmates of the facility shall be provided | ||||||
16 | with information on the transmission, prevention, | ||||||
17 | treatment, and containment of MRSA infections. | ||||||
18 | (B) Hand Hygiene procedures: Each facility shall | ||||||
19 | develop and implement hand hygiene procedures for | ||||||
20 | employees, residents, patients, students, and inmates | ||||||
21 | of the facility that includes adequate hand-washing | ||||||
22 | equipment and supplies and regular training on | ||||||
23 | effective hand hygiene techniques and education on the | ||||||
24 | importance of hand hygiene. These trainings must be | ||||||
25 | conducted at least twice each year and may be conducted | ||||||
26 | in conjunction with other trainings. |
| |||||||
| |||||||
1 | (C) Sanitation. Each facility shall develop and | ||||||
2 | implement sanitation procedures for cleaning and | ||||||
3 | disinfecting the environment that includes the | ||||||
4 | following: | ||||||
5 | (i) Use of an Environmental Protection Agency | ||||||
6 | (EPA)-registered disinfectant according to the | ||||||
7 | manufacturer's instructions. | ||||||
8 | (ii)
Regularly cleaning or disinfecting | ||||||
9 | washable surfaces in residents', patients', and | ||||||
10 | students' rooms, in inmates' cells, and in shared | ||||||
11 | areas such as showers, fitness areas, and food | ||||||
12 | services areas. | ||||||
13 | (iii)
Cleaning or disinfecting restraining | ||||||
14 | devices after every use. | ||||||
15 | (iv)
Treating all linen (towels, sheets, and | ||||||
16 | similar items) as potentially infectious and | ||||||
17 | following recommendations of the Centers for | ||||||
18 | Disease Control and Prevention for laundering. | ||||||
19 | (D) Personal protective equipment. Employees of | ||||||
20 | the facility shall be provided with personal | ||||||
21 | protective equipment (gloves, eye protection, and | ||||||
22 | gowns) for use when contact with blood, body fluids, or | ||||||
23 | wound drainage is likely. | ||||||
24 | (E) Isolation of residents, patients, students, or | ||||||
25 | inmates with MRSA. Each State residential facility | ||||||
26 | shall develop guidelines for isolating or cohorting |
| |||||||
| |||||||
1 | MRSA-diagnosed residents, patients, students, or | ||||||
2 | inmates from others when a clinician determines the | ||||||
3 | individual to be a high risk for spreading the | ||||||
4 | contagion. Residents, patients, students, or inmates | ||||||
5 | diagnosed with MRSA shall be examined by a clinician to | ||||||
6 | determine their risk of contagion to others. The | ||||||
7 | determination about whether to isolate residents, | ||||||
8 | patients, students, or inmates with MRSA infections | ||||||
9 | shall include consideration of the degree to which | ||||||
10 | wound drainage can be contained and the ability or | ||||||
11 | willingness of a resident, patient, student, or inmate | ||||||
12 | to comply with infection control instructions. | ||||||
13 | (4) Infection control.
Upon the diagnosis of a single | ||||||
14 | MRSA case at a State residential facility, that facility | ||||||
15 | shall implement surveillance measures to detect additional | ||||||
16 | MRSA cases through the following procedures: | ||||||
17 | (A) The individual diagnosed with MRSA shall be | ||||||
18 | interviewed to identify potential sources of | ||||||
19 | infections and close contacts. The interview should | ||||||
20 | seek to determine the date of onset and activity | ||||||
21 | immediately before and following onset, including | ||||||
22 | recent hospitalizations, housing, work assignments, | ||||||
23 | sharing of personal hygiene items, sexual contact, | ||||||
24 | participation in close-contact sports, or exposure to | ||||||
25 | other residents, patients, students, or inmates with | ||||||
26 | draining wounds or skin infections. |
| |||||||
| |||||||
1 | (B) Employees, residents, patients, students, or | ||||||
2 | inmates of the facility identified as having contact | ||||||
3 | with the infected individual should be examined for | ||||||
4 | signs and symptoms of infection and screened for | ||||||
5 | colonization. | ||||||
6 | (C) State residential facility management shall | ||||||
7 | inform all employees of the facility that an occurrence | ||||||
8 | of MRSA infection has been identified. The | ||||||
9 | notification must protect the identity and | ||||||
10 | confidential information of the infected individual. | ||||||
11 | Management shall immediately conduct training on MRSA | ||||||
12 | and hand hygiene, in addition to the training required | ||||||
13 | under subdivision (3)(B) of this Section, unless there | ||||||
14 | has been a confirmed case of MRSA at the facility | ||||||
15 | within the previous 6 months and a training was | ||||||
16 | conducted at that time. | ||||||
17 | (D) State residential facility management shall | ||||||
18 | inform all health care providers evaluating residents | ||||||
19 | or inmates of the facility of the MRSA infection | ||||||
20 | occurrence so they may be on the alert for inmates with | ||||||
21 | skin or soft tissue infections or other evidence of | ||||||
22 | MRSA infections. | ||||||
23 | (E) No resident, patient, student, or inmate with a | ||||||
24 | skin or soft tissue infection shall be transferred to | ||||||
25 | another facility until fully evaluated and | ||||||
26 | appropriately treated as described in this |
| |||||||
| |||||||
1 | subparagraph (E), except when required for security | ||||||
2 | reasons, medical care, or other special circumstances. | ||||||
3 | Residents, patients, students, or inmates with MRSA | ||||||
4 | infections requiring transfer shall have draining | ||||||
5 | wounds dressed the day of transfer to contain the | ||||||
6 | draining. Escort personnel shall be notified of the | ||||||
7 | resident, patient, student, or inmate's condition and | ||||||
8 | educated on infection control measures. The clinical | ||||||
9 | director of the sending facility or his or her designee | ||||||
10 | shall notify the receiving institution's clinical | ||||||
11 | director or health services administrator of pending | ||||||
12 | transfers of individuals with MRSA. This subparagraph | ||||||
13 | (E) does not apply to discharges and is not intended to | ||||||
14 | limit the individual's right to leave an institutional | ||||||
15 | setting. | ||||||
16 | (5) Treatment.
The Department of Public Health shall | ||||||
17 | develop a MRSA treatment protocol for each department | ||||||
18 | operating a State residential facility. Upon issuance of | ||||||
19 | the protocol by the Department of Public Health, each | ||||||
20 | department operating a State residential facility shall | ||||||
21 | educate all clinical staff at the facility and healthcare | ||||||
22 | vendors for the facility on that protocol.
| ||||||
23 | Section 99. Effective date. This Act takes effect upon | ||||||
24 | becoming law.
|